[6] Licht’s cancer career spans nearly three decades, and his research program covers over 30 years of continuous NCI and national foundation funding.
Licht leads a Specialized Center of Research program from the Leukemia and Lymphoma Society[7] and is principal investigator of three National Cancer Institute R01 grants.
He has trained over a dozen PhD and MD-PhD students and more than 30 postdoctoral fellows who have gone on to positions in academia and industry.
He has chaired the review panel for Specialized Center grants of the Leukemia and Lymphoma Society, served two years as chair of the Biochemical of the Mechanisms of Cancer Therapy-I study section of NIH and led the 2019 Gordon Conference on Cancer Genetics and Epigenetics.
[16] In 2024, he was named a 2023 Fellow of the American Association for the Advancement of Science (AAAS), a distinguished lifetime honor within the scientific community.